US 12,751,955 B2Granted

Formulation for oral administration, comprising triazine derivative

AssigneeShionogi & Co., Ltd.

InventorsMasato Gomi, Kensuke Horiuchi, Masayuki Morimoto, Keisuke Takagaki

Life of this patent

Estimating the term…

The present invention provides a formulation for oral administration, comprising a triazine derivative having virus proliferation inhibitory action.

Dependent claims

A solid formulation for oral administration, comprising a compound represented by Formula (VII):

its pharmaceutically acceptable salt, or a complex thereof, as an active ingredient.

Dependencies are inferred from the claim text.

A61K 31/53
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with three nitrogens as the only ring hetero…
A61K 9/1623
Organic compounds, e.g. phospholipids, fats: sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
A61K 9/1652
Organic macromolecular compounds: polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

From the US filing history. Foreign family members aren’t listed.

Loading patent…